bio & pharma
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity. synNotch is a trademark of Gilead/Kite.kyvernatx.com
Emeryville, CA, USA
Founded in 2018Inaccurate data? Flag it here.
Open jobs at Kyverna Therapeutics